Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |Streptavidin（SA） Hot |Claudin 18.2 |Cadherin-17 
0
There is no goods in the shopping cart !
My Cart|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CD171

CD171

Brief Information

Name:Neural cell adhesion molecule L1
Target Synonym:N-CAM-L1,NCAM-L1,CD171,MASA,SPG1,L1 Cell Adhesion Molecule,CD171 Antigen,MIC5,N-CAML1,Antigen Identified By Monoclonal Antibody R1,S10,CAML1,HSAS,HSAS1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CD1-H52H4 Human Human CD171 Protein, His Tag (MALS verified)
CD1-H52H4-structure
CD1-H52H4-sds
ACRO Quality

Part of Bioactivity data

CD1-H52H4-BLI
Human CD171, His Tag (Cat. No. ) MALS images

The purity of Human CD171, His Tag (Cat. No. CD1-H52H4) is more than 90% and the molecular weight of this protein is around 208-248 kDa verified by SEC-MALS.

Report
  • Background
    L1CAM is a cell adhesion molecule of the immunoglobulin superfamily which was originally discovered as a major player in the development of the nervous system. L1CAM was demonstrated to have prognostic value in different cancers and to be a promising target for anti-cancer therapy.
  • Clinical and Translational Updates
      

  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

Synonym Name

CD171/L1CAM

Background

L1CAM is a cell adhesion molecule of the immunoglobulin superfamily which was originally discovered as a major player in the development of the nervous system. L1CAM was demonstrated to have prognostic value in different cancers and to be a promising target for anti-cancer therapy.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
JCAR-023 JCAR-023 Phase 1 Clinical Seattle Children'S Hospital, Seattle Children'S Research Institute Neuroblastoma; Ganglioneuroblastoma Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap